Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)
Public ClinicalTrials.gov record NCT03768505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open Label Single-Arm, Phase 2 Study of Zandelisib (ME-401) in Subjects With Follicular Lymphoma and Marginal Zone Lymphoma After Failure of Two or More Prior Systemic Therapies (The TIDAL Study)
Study identification
- NCT ID
- NCT03768505
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MEI Pharma, Inc.
- Industry
- Enrollment
- 169 participants
Conditions and interventions
Interventions
- Zandelisib (ME-401) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2019
- Primary completion
- Mar 23, 2023
- Completion
- Mar 23, 2023
- Last update posted
- Dec 30, 2024
2019 – 2023
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oncology Institute of Hope and Innovation | Tucson | Arizona | 85710 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Tower Hematology Oncology | Beverly Hills | California | 90211 | — |
| The Oncology Institute of Hope and Innovation | Downey | California | 90241 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| H. Lee Moffit Cancer Center | Tampa | Florida | 33612 | — |
| Cleveland Clinic-Florida | Weston | Florida | 333331 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Advocate Health & Hospitals Corporation | Niles | Illinois | 61761 | — |
| Investigative Clinical Research of Indiana LLC | Indianapolis | Indiana | 46260 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| University of Michigan Medical School | Ann Arbor | Michigan | 48109 | — |
| St. Vincent Frontier Cancer Center | Billings | Montana | 59102 | — |
| The Oncology Institute of Hope and Innovation | Henderson | Nevada | 89052 | — |
| Memorial Sloan Kettering | Basking Ridge | New Jersey | 07920 | — |
| Memorial Sloan Kettering | Middletown | New Jersey | 07748 | — |
| Memorial Sloan Kettering | Montvale | New Jersey | 07645 | — |
| San Juan Oncology | Farmington | New Mexico | 87401 | — |
| Memorial Sloan Kettering | Commack | New York | 11725 | — |
| Memorial Sloan Kettering | Harrison | New York | 10604 | — |
| Clinical Research Alliance | Lake Success | New York | 11042 | — |
| Memorial Sloan Kettering | New York | New York | 10065 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| Memorial Sloan Kettering | Uniondale | New York | 11553 | — |
| Duke Cancer Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Vanderbilt University | Nashville | Tennessee | 37203 | — |
| Renovatio Clinical | Houston | Texas | 77056 | — |
| Swedish Cancer Institute | Edmonds | Washington | 98026 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Medical Oncology Associates PS | Spokane | Washington | 99208 | — |
| University of Wisconsin Carbone Cancer Center | Madison | Wisconsin | 53705 | — |
| Marshfield Medical Center | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03768505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03768505 live on ClinicalTrials.gov.